Covaxin: Bharat Biotech gets DCGI nod for Phase 3 trial of its coronavirus vaccine
The coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) — Covaxin, has been cleared for the third phase of clinical trials.
No comments:
Post a Comment